Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: 0.125% pilocarpine- No Comparator: Informed consent will be obtained from all the 50 eligible participants. Pupil size will be measured in all Participants with IOL Master 700 in photop
Sponsors
Ruby Moharana
Eligibility
Inclusion criteria
Inclusion criteria: Participants meeting ICD 3 criteria for migraine Participants having migraine with photophobia with light as the trigger factor for migraine Patients with BCVA of 6/6 Patients with normal anterior and posterior segment and normal IOP Patients with normal neurological assessment and normal MRI Patients volunteering to answer physicians questionnaire on HIT 6 and MIDAS
Exclusion criteria
Exclusion criteria: - Participants with no associated neurological disorder - Participants with no pre existing ocular conditions affecting pupil size - Participants with no recent eye surgeries - Participants not on any medications which can affect pupil size
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the impact of the 0.125% pilocarpine drops in reducing migraine-related disability using HIT-6 (Headache Impact Test) scores and MIDAS (Migraine Disability Assessment) scores.Timepoint: Day 0, Day 30 (HIT-6 scores), Day 90 (MIDAS Scores) | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effect of 0.125% pilocarpine on the pupil sizes of migraine patients with photophobia.Timepoint: Day 30, Day 90 | — |
Countries
India
Contacts
Public ContactRuby Moharana
Apex Eye Care
Outcome results
None listed